None listed
Conditions
Interventions
Others : In both control group and intervention group, basic educational materials are provided, and standard treatment is performed in accordance with the guidelines of the Korean Diabetes Associatio
Sponsors
The Catholic University of Korea, St. Vincent's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All of the following criteria must be satisfied to participate in this clinical trial. 1) Subjects with type 2 diabetes who require self-monitoring of blood glucose 2) Men and women between the ages of 19 and 75 3) Baseline HbA1c = 7.5% 4) BMI = 18.5 kg/m2 5) Subjects who can use a smartphone 6) Subjects who have agreed to participate in this clinical trial and have given their written consent
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Subjects with an insulin pump 2) Subjects with chronic kidney disease with eGFR <30 ml/min 3) Subjects with New Your Heart Association (NYHA) classification III-IV 4) Subjects with a malignant tumor within the last 5 years and have not completed treatment 5) Organ transplant recipients or those who need to take long-term immunosuppressants 6) Subjects with difficulty in movement or activity due to spinal diseases (disc herniation, spinal stenosis), other joint diseases, and major surgery at the time of screening 7) Subjects who plan to undergo surgery that is considered to have restrictions on post-operative activities during the clinical trial period 8) Pregnant or lactating women 9) Subjects who are planning to become pregnant during the clinical trial period or who do not agree to use appropriate contraception 10) Subjects who participated other clinical trials within 90 days of screening (excluding observational studies) 11) Subjects who are judged to be inappropriate to participate in clinical trials at the time of the investigator's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in HbA1c level from baseline to week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in fasting glucose level from baseline to week 12;Percentages of subjects who meet HbA1c <7.0% at week 12;Percentages of subjects who meet HbA1c <6.5% at week 12;Hypoglycemia-related hospital visits from baseline to week 12;Hyperglycemia-related hospital visits from baseline to week 12;Changes in lipidil profile (total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol) from baseline to week 12;Changes in self-care management (physical activity, eating behavior, sleep pattern) from baseline to week 12 | — |
Countries
Korea, Republic of
Contacts
Public ContactKyuho Kim
The Catholic University of Korea, St. Vincent's Hospital
Outcome results
None listed